A new polymeric silver(I) complex, [Ag 2 (L 1 ) 2 (L 2 )(OH 2 )] n , was obtained by the reaction of 3-aminopyrazine-2-carboxylic acid (HL 1 ), 2-amino-5-methylpyridine (L 2 ) and silver oxide in aqueous ammonia. The complex was characterized by elemental analysis, IR spectra and single crystal X-ray determination. The smallest repeat unit contains a [Ag 2 (L 1 ) 2 (L 2 )(OH 2 )] moiety. The Ag···Ag distance is 7.490(2) Å. One Ag atom is coordinated by three pyrazine N and two carboxylate O atoms from four L 1 ligands, forming a square pyramidal coordination, and the other one is coordinated by one pyrazine N and one carboxylate O atoms from a L 1 ligand, one pyridine N atom from a L 2 ligand, and one water O atom, forming a square planar geometry. In the crystal structure of the complex, the dinuclear silver moieties are linked through L 1 ligands, to form 1D chains along the x-axis direction. The chains are further linked through intermolecular hydrogen bonds in the y-and z-axis directions, forming a 3D network. In addition, there are π···π interactions among the chains. The complex showed effective cytotoxic property on human lung cancer cell line A549.
INTRODUCTION
The compounds bearing both pyridine/pyrazine and carboxylate groups are a kind of interesting ligands for the coordination of silver, and such complexes have received particular attention in coordination chemistry [1] [2] [3] [4] [5] . Silver has versatile coordination numbers and geometries [6] [7] [8] [9] [10] . By varying the synthetic method, solvents, anions, and proportion of starting materials, one can construct different structures of silver complexes. But until now, one can not precisely predicates what structures will be finally formed for the silver complexes. So, more work needs to be carried out to understand the influence effects of such complexes. In addition, most silver complexes have shown interesting luminescence property [11] [12] [13] and biological activities [14] [15] [16] [17] . Lung cancer is one of the most common and life-threatening malignancies worldwide. The poor prognosis of lung cancer is largely attributed to the frequent occurrence of metastasis, since most metastatic tumours are unresectable at the time of presentation. The severe morbidity and poor prognosis of lung cancer highlight the importance of searching for new and effective agents against lung cancer 18, 19 . It is notable that the cytotoxicity property of the silver complexes has received particular attention [20] [21] [22] . 3-Aminopyrazine-2-carboxylic acid (HL 1 ) is a hopeful ligand containing carboxylic group, amine and pyrazine nitrogen atoms. Some nickel, cobalt, mercury, zinc, manganese and lanthanide [23] [24] [25] [26] [27] [28] complexes derived from HL 1 have been reported. However, no silver complex has been reported so far. In the present work, a new polymeric silver(I) complex, [Ag 2 (L 1 ) 2 (L 2 ) (OH 2 )] n , is presented. The aim was to investigate the anticancer effects of the complex on human lung cancer cell A549.
EXPERIMENTAL
Materials and Measurements: 3-Aminopyrazine-2-carboxylic acid, 2-amino-5-methylpyridine and silver oxide were purchased from Fluka and used as received. The solvents used were of reagent grade. Elemental analyses were carried out using a Perkin-Elmer 2400 II elemental analyser. The infrared spectrum was recorded on a Perkin-Elmer FT-IR spectrophotometer with a KBr disc. The X-ray diffraction was carried out on a Bruker SMART 1000 CCD area diffractometer at 298(2) K.
Synthesis of the complex. 3-Aminopyrazine-2-carboxylic acid (0.28 g, 2 mmol) and Ag 2 O (0.23 g, 1 mmol) were mixed and stirred in a 30% aqueous ammonia (30 mL). The mixture was stirred at room temperature until all solid dissolved. Then, to the mixture was added 2-amino-5-methylpyridine (0.11 g, 1 mmol). 
X-ray Crystallography:
A suitable single crystal of the complex was mounted on the top of a glass fiber. Graphite-monochromatized Mo-Ka radiation (l = 0.71073 Å) and the ω scan technique were used to collect the diffraction data. Absorption correction was applied with SADABS 29 . The structure of the complex was solved with direct method and refined with a full-matrix least-squares technique with SHELXTL 30 . Anisotropic thermal parameters were applied to all non-hydrogen atoms. The hydrogen atoms of the amino groups were located from electronic density maps, with N-H and H···H distances restrained to 0.90(1) and 1.43(2) Å, respectively. The other hydrogen atoms were generated geometrically. The crystallographic data and the details of the data collection and refinement for the complex are listed in Table 1 . Selected bond lengths and angles are given in Table 2 . Hydrogen bonding information is given in Table 3 . Table 2 . Selected bond lengths (Å) and angles (º) for the complex. 
RESULTS AND DISCUSSION

Synthesis:
The synthetic procedure of the complex is described as follows:
In the present complex, the Ag atom combines with the pyrazine N and carboxylate O atoms, instead of the amino N atom. This is due to the strain of the five-membered chelate ring is weaker than the four-membered chelate ring. Elemental analyses of the complex are in good agreement with expected values. Even though most silver complexes are sensitive to light, the present sample is very stable.
Infrared Spectrum: The weak and sharp absorption at 3287 cm -1 is resulted from the N-H vibrations of the amino groups. The ν as (COO) is related to the strong band observed at 1613 cm -1 , whereas the ν s (COO) is attributed to the medium band observed at 1376 cm -1 . This gives rise to a Δν of 237 cm -1 characteristic of bidentate coordination of the carboxylate group 32 . Structure Description of the Complex: The molecular structure of the complex is shown in Figure 1 . The smallest repeat unit contains a [Ag 2 (L 1 ) 2 (L 2 ) (OH 2 )] moiety. The Ag (1)···Ag (2) 33, 34 . In the crystal structure of the complex, Figures 2 and 3 , the dinuclear silver moieties are linked through L 1 ligands, to form 1D chains along the x-axis direction. The chains are further linked through intermolecular hydrogen bonds (Table 3) in the y-and z-axis directions, forming a 3D network. In addition, there are π···π interactions among the chains (Table 4 ). Cytotoxic Property: A549 lung cancer cells and L-02 human normal liver cell were used by MTT method to study the growth inhibitory effects of the complex. The IC 50 values for the complex are 14.2 ± 1.3 μM for A549 and 57.3 ± 3.7 μM for L-02. As a comparison, the silver nitrate and cisplatin showed IC 50 values of 8.7 ± 0.9 μM and 6.9 ± 1.1 μM for A549, and the ligands themselves showed no activity. Thus, the cytotoxic property of the complex is to some extent weak than the silver nitrate and cisplatin. However, considering the obvious side effects of the silver nitrate and cisplatin, the present silver complex is also a promising drug, which deserves further study.
Appendix A. Supplementary data CCDC -1008308 for the complex contain the supplementary crystallographic data for this paper. These data can be obtained free of charge at http://www.ccdc.cam.ac.uk/const/retrieving.html or from the Cambridge Crystallographic Data Centre (CCDC), 12 Union Road, Cambridge CB2 1EZ, UK; fax: +44(0)1223-336033 or e-mail: deposit@ccdc.cam.ac.uk. 
